Safety and Efficacy of Xalkori ROS1

NCT03375242 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

97

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG: crizotinib

Sponsor

Pfizer